Document is current
Any future updates will be listed below
-
Authors
Yu, Guoyu
Wei, Fang
Li, Wanying
Guo, Qiuyun
Zhang, Lihong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81803009)
Chen Xiaoping Foundation for the development of science and technology of Hubei province (CXPJJH122006-1027)
Chinese Society of Clinical Oncology research found (Y-L2018-003, Y-sy2018-039)
CSCO-BMS Immune-Oncology Research Fund (Y-BMS 2019-011)
Natural Science Foundation of Hubei Province (2024AFB995)
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 23 July 2025
First Online: 9 August 2025
Declarations
:
: The use of animals and the procedures followed were approved by the Animal Care and Use Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (No.202207001). The ovarian cancer tissue microarray specimens were used with approval from the Ethics Committee of Shanghai Outdo Biotech Co. Ltd. (No. YBM-05-02). We performed all methodologies in compliance with pertinent guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
